A Ti3 C2 TX /Pt-Pd based amperometric biosensor for sensitive cancer biomarker detection

Electrophoresis. 2022 Oct;43(20):2033-2043. doi: 10.1002/elps.202100218. Epub 2022 Jul 20.

Abstract

The detection of cancer biomarkers is of great significance for the early screening of cancer. Detecting the content of sarcosine in blood or urine has been considered to provide a basis for the diagnosis of prostate cancer. However, it still lacks simple, high-precision and wide-ranging sarcosine detection methods. In this work, a Ti3 C2 TX /Pt-Pd nanocomposite with high stability and excellent electrochemical performance has been synthesized by a facile one-step alcohol reduction and then used on a glassy carbon electrode (GCE) with sarcosine oxidase (SOx ) to form a sarcosine biosensor (GCE/Ti3 C2 TX /Pt-Pd/SOx ). The prominent electrocatalytic activity and biocompatibility of Ti3 C2 TX /Pt-Pd enable the SOx to be highly active and sensitive to sarcosine. Under the optimized conditions, the prepared biosensor has a wide linear detection range to sarcosine from 1 to 1000 µM with a low limit of detection of 0.16 µM (S/N = 3) and a sensitivity of 84.1 µA/mM cm2 . Besides, the reliable response in serum samples shows its potential in the early diagnosis of prostate cancer. More importantly, the successful construction and application of the amperometric biosensor based on Ti3 C2 TX /Pt-Pd will provide a meaningful reference for detecting other cancer biomarkers.

Keywords: Pt-Pd bimetallic nanoparticles; Ti3C2TX MXene; electrochemical biosensor; prostate cancer diagnosis; sarcosine detection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor
  • Biosensing Techniques* / methods
  • Carbon / chemistry
  • Humans
  • Lead
  • Limit of Detection
  • Male
  • Platinum
  • Prostatic Neoplasms* / diagnosis
  • Sarcosine
  • Sarcosine Oxidase / chemistry
  • Titanium

Substances

  • Biomarkers, Tumor
  • Carbon
  • Sarcosine
  • Sarcosine Oxidase
  • Titanium
  • Platinum
  • Lead